2nd Quarter - Report
SOLVAY PHARMACEUTICALS, INC. for SOLVAY PHARMACEUTICALS INC
Client
Income
—
Expenses
$60,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Extension of the research and development tax credit H.R. 6049 S. 3125 S 2886
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATROSKI LAWSON | — |
Medicare/Medicaid MMM
Formulary requirements for certain classes of drugs. S. 3101
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATROSKI LAWSON | — |
Pharmacy PHA
Implementation of national strategy to prepare for pandemic influenza. FY 2009 Labor, HHS appropriations bill
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATROSKI LAWSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.